期刊文献+

乳腺基底细胞样癌的临床病理观察 被引量:5

Clinicopathological characteristics of breast basal-like carcinoma
下载PDF
导出
摘要 目的探讨乳腺基底细胞样癌(basal-like carcinoma,BLC))的临床病理特征、免疫表型特点及预后。方法收集乳腺BLC12例,总结其临床资料、大体及组织病理学特征,并进行免疫组化EnVision法染色。选用的抗体包括CK5/6、vimentin、CK8、ER、PR及c-erbB-2等。结果本组患者均为女性,发病平均年龄40.4岁。12例乳腺BLC均为组织学Ⅲ级。肿瘤表现为无腺管的富于细胞的实性结构,周围有较少的纤维结缔组织间隔;大多数表现为推进式生长方式,周围有大量淋巴细胞浸润;排列呈实性巢状、片状、团块状及粗大带状结构伴有片状地图样坏死,肿瘤中央可出现无细胞结构的纤维瘢痕。肿瘤细胞胞质少呈合体状,核为圆形、卵圆形,胞核胞质比例高,核分裂象活跃。12例乳腺BLC的免疫表型均为ER、PR及c-erbB-2阴性,而CK5/6、CK8及vimentin阳性。结论乳腺BLC是一种新的乳腺癌类型,具有独特的免疫组化特征、组织形态学特点及生物学特性,应作为一种独立的乳腺癌亚型加以认识。 Purpose To investigate the clinicopathological features, immunophenotype and prognosis of breast basal-like carcinoma (BLC). Methods 12 cases of breast BLC were analyzed with respect to clinical information and pathological features. Immunohisto- chemical study (EnVision method, for cytokeratin 5/6, cytokeratin 8, vimentin, estrogen receptor, progesterone receptor, c-erbB-2) was performed. Results All the patients were females with a mean age of 40. 4 years. Histologically, the tumors were grade 3 ductal carcinoma. The tumors showed solid architecture with no tubule formation and a high density of tumor cells with scant intervening stroma between tumor cells. The majority of tumors showed a pushing growth pattern and had some degree of a stromal lymphocytic infiltrate at the tumor edge. The tumor cells were arranged in solid-nests, sheets, cords and regions of ribbon-like architecture with associated central geographic necrosis and showed a central acellular fibrotic zone. The tumor cells contained scant cytoplasm and round to oval nuclei producing a high nuclear/cytoplasmic ratio and showed syncytial growth. A high mitotic rate was identified in all tumors. The consistent immunophenotype seen in the basal-like tumors was negativity for ER, PR and e-erbB-2, and positivity for cytokeratin 5/6, vimentin and cytokeratin 8. Conclusions Breast BLC is a new subtype of breast carcinoma with unique immunophenotype, distinctive morphological features and prognosis. Conventional light microscopy usually permits a correct diagnosis.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2008年第4期432-435,438,共5页 Chinese Journal of Clinical and Experimental Pathology
关键词 乳腺肿瘤 基底细胞样癌 免疫组织化学 breast neoplasms basal-like carcinoma immunohistochemistry
  • 相关文献

参考文献20

  • 1Perou C M,Sorlie T,Eisen M B,et al.Molecular portraits of human breast tumours[J].Nature,2000,406:747-752.
  • 2Sorlie T,Perou C M,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications[J].Proc Natl Acad Sci USA,2001,98:10869-10874.
  • 3Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets [J].Proc Natl Acad Sci USA,2003,100:8418-8423.
  • 4Kesse-Adu R,Shousha S.Myoepithelial markers are expressed in at least 29%of oestrogen receptor negative invasive breast carcinoma[J].Mod Pathol,2004,17:646-652.
  • 5Nielsen T O,Hsu F D,Jensen K,et al.Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcimoa[J].Clin Cancer Res,2004,10:5367-5374.
  • 6Jones C,Ford E,Gillett C,et al.Molecular cytogenetic identification of sub-groups of grade Ⅲ invasive ductal breast carcinomas with different clinical outcomes[J].Clin Cancer Res,2004,10:5988-5997.
  • 7Livasy C A,Karaca G,Nanda R,et al.Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma[J].Mod Pathol,2006,19:264-271.
  • 8Malzahn K,Mitze M,Thoenes M,et al.Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas[ J ]. Virchows Arch, 1998,433 : 119 - 129.
  • 9Tsuda H, Takarabe T, Hasegawa T, et al. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones[ J]. Hum Pathol, 1999, 30 : 1134 - 1139.
  • 10Van de Rijn M, Perou C M, Tibshirani R, et al. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome[ J]. Am J Pathol, 2002, 161 : 1991 - 1996.

同被引文献74

  • 1赵健,吴一龙,王远东,赵光日,王建.新辅助化疗对乳腺癌雌、孕激素受体和HER-2的影响[J].第一军医大学学报,2004,24(12):1437-1439. 被引量:9
  • 2牛昀,张建中.对乳腺新病变的认识和老病变的再评价[J].临床与实验病理学杂志,2007,23(2):133-136. 被引量:2
  • 3Sorlie T, Tibshirani R, Parker J, et al. Repeated observation of breast tumor subtypes in independent gene expression dala sets [ J ]. Proe Natl Sei USA ,2003,100( 14 ) :8418 - 8423.
  • 4Perou C M,Sorlie T, Eisen M B,et al. Molecular portraits of human breast tumours [ J ]. Natrue ,2000,406 ( 6797 ) :747 - 752.
  • 5Livasy C A, Karaca G, Nanda R ,et al. Phenotypic evaluation of the basalqike subtype of invasive breast carcinoma[ J]. Mod Pathol, 2006,19(2) :264 -271.
  • 6Nielsen T O, Hsu F D, Jansen K,et al. Immunohistochemieal and clinical characterization of the basal-like subtype of invasive breast carcinoma[J]. Clin Cancer Res,2004,10(16) :5367 -5374.
  • 7Tavassoli F A,Devilee P. World Health Organization classification of tumors. Pathology and genetics, tumors of the breast and female genital organs [ M ]. Lyon : IARC Press ,2003 : 19.
  • 8Matos I, Dufloth R, Alvarenga M, et al. p63, cytokeratin 5, and Peadherin: three molecular markers to distinguish basal phenotype in breast carcinomas [ J ]. Virchows Arch, 2005,447 (4) : 688 - 694.
  • 9Gatalica Z, Ide S M, Rampy B A,et al. The expression of Fhit protein is related inversely to disease progression in patient with breast carcinoma[ J]. Cancer,2000,88 (6) :1378 - 1383.
  • 10Jones C, Ford E, Gillett C, et al. Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes [ J ]. Clin Cancer Res,2004, 10 ( 18 Ptl ) :5988 -5997.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部